Dupilumab Pregnancy Registry Shows No Birth Defect Signal
The dupilumab pregnancy registry has detected no increased rate of birth defects with exposure during pregnancy, per Tina Chambers, PhD, MPH, in a new interview with HCPLive.
Topic
Drug Registry
Topic